CLINICAL_TRIALS ClinicalTrials.gov record update

A Double Blind, Placebo Controlled Pivotal Phase III Study Evaluating Xilonix™ in Symptomatic Colorectal Cancer Patients Refractory to Standard Therapy

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02138422
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:17.464577+00:00
Published At: 2021-03-01T00:00:00+00:00
Record Updated At: 2021-03-01
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Symptomatic Colorectal Cancer", "Advanced Colorectal Cancer", "Colorectal Cancer With Cachexia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2021-03-01"
protocolSection.identificationModule.nctId: "NCT02138422"
protocolSection.identificationModule.officialTitle: "A Double Blind, Placebo Controlled Pivotal Phase III Study Evaluating Xilonix\u2122 in Symptomatic Colorectal Cancer Patients Refractory to Standard Therapy"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.